Showing results (71-80 of 1,357) with videos related to
Sort By:
Pageof 136
Endocrinology|September 1, 1978
Further studies on the role of calcium in glucocorticoid-induced lymphocytolysisN Kaiser, I S EdelmanThe Journal of Clinical Investigation|August 1, 1971
Effects of Ca++ and prostaglandin E1 on vasopressin activation of renal adenyl cyclaseF Marumo, I S EdelmanThe American Journal of Physiology|February 1, 1984
Extravascular CBG-like sites in rat kidney and mineralocorticoid receptor specificityG Stephenson, Z Krozowski, J W FunderClinical Endocrinology|November 1, 1983
Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptorsD Armanini, I Karbowiak, J W FunderAmerican Journal of Hypertension|October 6, 1999
Involvement of aldosterone in left ventricular hypertrophy of patients with end-stage renal failure treated with hemodialysisA Sato, J W Funder, T SarutaJournal of Neuroendocrinology|February 13, 2009
Chloroquine Decreases Adrenocorticotrophin-Secretory Response to Corticotrophin-Releasing Factor but not to Vasopressin in Rat Pituitary Cells: Further Evidence for Differentially Responsive SubpopulationsJ Schwartz, T Pham, J W FunderEuropean Journal of Pharmacology|January 8, 1985
A kappa-selective opioidergic pathway is involved in the reversal of a behavioural effect of adrenalectomyD Jefferys, J Boublik, J W FunderClinical Science and Molecular Medicine. Supplement|December 1, 1976
SC 23992: radioreceptor assays for therapeutic and side effectsJ W Funder, J Mercer, J HoodEuropean Journal of Pharmacology|August 17, 1984
Naloxone inhibits both glucocorticoid and [D-Ala2,Met5]enkephalinamide reversal of behavioural effect of adrenalectomyD Jefferys, D Copolov, J W FunderClinical and Experimental Pharmacology & Physiology|January 1, 1987
High-affinity aldosterone binding in rat liver--a re-evaluationA Zaini, P Pearce, J W FunderPageof 136